Creative Planning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.2M Buy
337,132
+10,654
+3% +$1.02M 0.02% 318
2025
Q4
$31.4M Buy
326,478
+36,782
+13% +$3.57M 0.02% 281
2025
Q3
$27.6M Buy
289,696
+36,586
+14% +$3.36M 0.02% 292
2025
Q2
$22.1M Sell
253,110
-8,366
-3% -$709K 0.02% 317
2025
Q1
$23.5M Buy
261,476
+45,858
+21% +$4.1M 0.02% 290
2024
Q4
$17.2M Sell
215,618
-8,122
-4% -$703K 0.02% 322
2024
Q3
$20.1M Sell
223,740
-23,321
-9% -$1.96M 0.02% 283
2024
Q2
$19.4M Buy
247,061
+15,305
+7% +$1.25M 0.02% 277
2024
Q1
$20.2M Buy
231,756
+5,883
+3% +$502K 0.02% 261
2023
Q4
$18.6M Sell
225,873
-1,093
-0.5% -$83.3K 0.03% 249
2023
Q3
$17.8M Buy
226,966
+82,413
+57% +$6.9M 0.02% 256
2023
Q2
$12.7M Buy
144,553
+16,078
+13% +$1.38M 0.02% 301
2023
Q1
$10.4M Buy
128,475
+2,311
+2% +$188K 0.01% 329
2022
Q4
$9.81M Sell
126,164
-26,772
-18% -$2.17M 0.01% 341
2022
Q3
$12.3M Sell
152,936
-2,442
-2% -$219K 0.02% 263
2022
Q2
$13.9M Buy
155,378
+9,452
+6% +$958K 0.02% 257
2022
Q1
$16.2M Buy
145,926
+36,780
+34% +$3.89M 0.03% 241
2021
Q4
$11.3M Sell
109,146
-2,177
-2% -$252K 0.02% 263
2021
Q3
$14M Buy
111,323
+5,620
+5% +$727K 0.02% 215
2021
Q2
$13.1M Sell
105,703
-39,620
-27% -$4.97M 0.02% 223
2021
Q1
$17.2M Sell
145,323
-4,492
-3% -$526K 0.03% 192
2020
Q4
$17.5M Buy
149,815
+25,429
+20% +$2.8M 0.04% 176
2020
Q3
$12.9M Buy
124,386
+9,499
+8% +$954K 0.03% 179
2020
Q2
$10.5M Buy
114,887
+4,639
+4% +$445K 0.03% 189
2020
Q1
$9.94M Sell
110,248
-6,549
-6% -$697K 0.04% 173
2019
Q4
$13.3M Sell
116,797
-2,201
-2% -$242K 0.04% 159
2019
Q3
$12.9M Sell
118,998
-9,606
-7% -$1M 0.04% 151
2019
Q2
$12.5M Buy
128,604
+5,049
+4% +$461K 0.04% 153
2019
Q1
$11.3M Sell
123,555
-3,474
-3% -$311K 0.04% 149
2018
Q4
$11.6M Buy
127,029
+21,053
+20% +$1.97M 0.05% 132
2018
Q3
$10.4M Buy
105,976
+4,090
+4% +$378K 0.04% 158
2018
Q2
$8.72M Sell
101,886
-4,596
-4% -$384K 0.03% 170
2018
Q1
$8.54M Buy
106,482
+5,463
+5% +$451K 0.03% 161
2017
Q4
$8.16M Buy
101,019
+3,773
+4% +$302K 0.04% 170
2017
Q3
$7.56M Sell
97,246
-1,978
-2% -$164K 0.04% 175
2017
Q2
$8.81M Sell
99,224
-5,198
-5% -$438K 0.04% 151
2017
Q1
$8.41M Buy
104,422
+3,626
+4% +$283K 0.05% 152
2016
Q4
$7.18M Sell
100,796
-3,316
-3% -$261K 0.04% 165
2016
Q3
$8.99M Buy
104,112
+37,317
+56% +$3.25M 0.06% 130
2016
Q2
$5.8M Buy
66,795
+1,108
+2% +$89.6K 0.04% 159
2016
Q1
$4.93M Buy
65,687
+1,561
+2% +$118K 0.04% 164
2015
Q4
$4.93M Sell
64,126
-404
-0.6% -$30.4K 0.04% 164
2015
Q3
$4.32M Buy
64,530
+11,314
+21% +$833K 0.04% 170
2015
Q2
$3.94M Sell
53,216
-2,433
-4% -$186K 0.04% 176
2015
Q1
$4.34M Buy
55,649
+5,706
+11% +$432K 0.04% 161
2014
Q4
$3.61M Sell
49,943
-3,868
-7% -$269K 0.04% 175
2014
Q3
$3.33M Buy
53,811
+20,598
+62% +$1.31M 0.04% 171
2014
Q2
$2.12M Sell
33,213
-3,129
-9% -$190K 0.03% 218
2014
Q1
$2.24M Buy
36,342
+4,704
+15% +$274K 0.03% 181
2013
Q4
$1.82M Sell
31,638
-2,060
-6% -$117K 0.03% 196
2013
Q3
$1.79M Buy
33,698
+4,975
+17% +$268K 0.04% 165
2013
Q2
$1.48M Buy
+28,723
New +$1.42M 0.03% 175

Other funds holding MDT

Creative Planning's MDT Position: Q1 2026 in Review

Creative Planning increased its Medtronic (MDT) stake by 3.3% in Q1 2026, buying an estimated $1.02M and bringing the position to 337,132 shares worth $29.2M. The position accounts for 0.02% of the portfolio, ranked #318.

Creative Planning first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.4M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Creative Planning held 337,132 shares of Medtronic worth $29.2M as of Q1 2026.
  • Creative Planning bought 10,654 Medtronic shares in Q1 2026, an estimated $1.02M.
  • Medtronic made up 0.02% of Creative Planning's portfolio in Q1 2026, its #318 holding.
  • Creative Planning first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Creative Planning's Medtronic position peaked at $31.4M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.